These results are in agreement with the report by Laurent et al. of NOX1 mRNA being upregulated in 57% of a 24 patient colon cancer cohort that was compared to adjacent normal colonic tissue from the same patients, a trend that correlated with activating mutations in KRAS codons 12 and 13 [62]. Here, KRAS is linked to colonic neoplasm.